You are not logged in to Prodigits. Please register or login.

Subject: glaucoma drugs
Replies: 4 Views: 237

bozzalad 14.03.18 - 10:12pm
New glaucoma drugs yield large, lasting reductions in intraocular pressure
New Rochelle, NY, February 21, 2018-Two novel ocular hypotensive agents that have just been approved for use in humans -- netarsudil and latanoprostene bunod (LBN) -- greatly reduce intraocular pressure, with lasting results in various animal models of glaucoma and in humans. Two articles that highlight these two breakthrough drugs, as well as cutting-edge articles on the effects of amitriptyline in dry eye disease and emerging microneedles to delivery intraocular drugs are part of a new special issue of Journal of Ocular Pharmacology and Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Journal of Ocular Pharmacology and Therapeutics website. * +

ladibud 15.03.18 - 06:10am
* +

birdy 15.03.18 - 07:11am
What happened to weed being useful for glaucoma? * +

bozzalad 15.03.18 - 09:23am
It still can be i think. Cbd oil certainly helps with diabetes * +

bambi99 15.03.18 - 10:11am
It should be cultivated as a cash crop globally imo ...although I bet the pharmaceutical industry won't like it.. *

+ refresh
+ my page
+ functions
3 search
4 submit a reply
+ bookmark
8 General Chat Forum
9 Forum Index

Custom Search